P300-2037 Screening compound: N-(2,5-difluorophenyl)-5-[(4-fluorophenyl)methyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide

P300-2037 Screening compound: N-(2,5-difluorophenyl)-5-[(4-fluorophenyl)methyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide
P300-2037 Screening compound: N-(2,5-difluorophenyl)-5-[(4-fluorophenyl)methyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P300-2037
N-(2,5-difluorophenyl)-5-[(4-fluorophenyl)methyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P300-2037

Molecular Formula

C24H15F3N4O2 (C24 H15 F3 N4 O2)

Compound Name

N-(2,5-difluorophenyl)-5-[(4-fluorophenyl)methyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide

IUPAC name

N-(25-difluorophenyl)-5-[(4-fluorophenyl)methyl]-4-oxo-4H5H-pyrazolo[15-a]quinoxaline-7-carboxamide

SMILES

O=C(c(cc1)cc(N2Cc(cc3)ccc3F)c1-n1nccc1C2=O)Nc(cc(cc1)F)c1F

InChI

InChI=1S/C24H15F3N4O2/c25-16-4-1-14(2-5-16)13-30-22-11-15(23(32)29-19-12-17(26)6-7-18(19)27)3-8-20(22)31-21(24(30)33)9-10-28-31/h1-12H,13H2,(H,29,32)

InChI Key

OXCRULHCQMFADB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD28993230

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.4

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.286

Distribution Coefficient, logD

4.171

Water Solubility, LogSw

-4.42

Polar Surface Area

50.232

Acid Dissociation Constant (pKa)

7.92

Base Dissociation Constant (pKb)

0.39

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

4.20

P300-2037 in Drug Discovery

Included in Screening Libraries

Nucleic Acid Ligands (8311 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system

References: we are preparing a list of scientific research reports with P300-2037 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P300-2037?
Check Price and Availability of P300-2037, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P300-2037 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P300-2037
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P300-2037
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P300-2037 available by request